Skip To Main Content
Robert E.J on Muck Rack

Robert E.J

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Robert E.J’s profile

Articles by Robert E.J

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

|
By James Byrne, Robert E.J, Diakonissensanstalt Emmaus Niesky
| Diabetes Spectrum
Funding. The ABCD provided funding to support the establishment of the ABCD Worldwide EndoBarrier Registry. Duality of Interest. R.E.J.R. has received speaker fees, consultancy fees, and/or educational sponsorships from Abbott, BioQuest, GI Dynamics, and Novo Nordisk. J.S. and K.L. have received honoraria for speaker bureau, consultancy, and research funding from GI Dynamics. No other potential conflicts of interest relevant to this article were reported. Author Contributions.
Open in Who Shared Issue with article?

Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide

|
By Robert E.J, de Jonge, Sen Gupta
| gla.ac.uk
Ryder, R. E.J. et al. (2023) Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide. Diabetes Care, (doi: 10.2337/dc22-1952) (PMID:36716004) (Early Online Publication) Full text not currently available from Enlighten. Abstract No abstract available.
Open in Who Shared Issue with article?

Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19

|
By Kansas City, Benjamin C.T, Robert E.J
| Diabetes Spectrum
To our knowledge, this is the largest multicenter study reporting data on DKA and mortality in people with T2D admitted to hospital with COVID-19 that investigates association with SGLT2is preadmission and suggests that that, despite limited power, there is no evidence for association. Only a few small studies or case studies have recently reported high rates of DKA in people hospitalized with COVID-19, particularly in those with T2D (15).
Open in Who Shared Issue with article?
Show More